Prepared for Latent · September 2026
26 of Latent's customers are already selling for you. Almost nobody can see them.
Your customers are advocating for Latent right now, with or without you. We audited the public record: the champions are already there, with a model of what their voices are worth in feeds and AI answers. What it sets up is the decision below: whether to turn this into a channel you actually run.
On the public record3 / 3Why this audit exists, and what happens when you claim it
Nobody has to sell you on word of mouth. It is the strongest voice in your market, and the people quoted above are proof it is already working for Latent, with or without you. Belief was never the problem.
Until now there has been no way to manage and amplify customer voice without ruining what makes it credible: assignment platforms turn it into advertising, portals turn it into homework. So at most companies the channel runs itself, by accident. The audit quantifies what that accident is worth at Latent, champion by champion, with sources.
Champions enrolled, speaking on their own terms, measured, and paid fairly. Organic by design: we never assign content or set quotas, because the moment you do, buyers can tell. We build it with you, or you run it on the platform. The audit is step one.
The best finds
What the public record says, and what it leaves on the table
The full audit carries the complete record.
Champions already on the record
Named executives are publicly endorsing Latent, in their own words, on pages anyone can check. They cleared legal, went on record, and would say it again.
A loud brand, a silent customer bench
Latent's feed is working: launches, press, real attention. But the voice buyers discount least, the customer's, appears in none of it. The advocacy channel is running unowned, growing or stalling by accident.
The feed your buyers read, and the answers AI gives them
B2B evaluation now starts in feeds and AI assistants. The Meltwater and LinkedIn study of 9.5 million AI citations shows the cited voices are overwhelmingly people, not brands. Whoever owns the credible customer voice in a category owns the shortlist conversation.
So you can
Turn your best marketing channel into something you can measure, predict, and grow.
Your customers become your best salespeople: real users telling their peers, in their own words, why they chose Latent. That is Advocacy-Led Growth, and it makes your highest quality channel measurable and predictable instead of accidental. Word of mouth always had the credibility. What it never had was infrastructure. Kindling helps you build the system for it.
Start with Latent's free audit →Champions already on record
The strongest voices from the full audit.
“It is a privilege to work with Latent, and we are excited to further strengthen this collaboration, building new efficiencies and setting new standards of excellence across our system.”
“Health systems talk about infrastructure like bridges and tunnels—we need the same mindset for technology. Latent supports critical infrastructure behind the scenes so our people can focus on patients.”
“We value the Latent AI program for its ability to streamline the collection of clinical information directly from the chart, supporting more efficient workflows.”
Why now
Latent's LinkedIn feed already carries attention from investors, partners, and the brand itself. What is missing is recurring customer voice in that same feed. You already know word of mouth is the best advertising there is. The difference between having it and running it as a channel is a system. Champions activated while the spotlight is on compound every dollar of attention the brand is earning. [source]
What activation looks like
A first ninety days, sized for a lean team
Consolidate the scattered proof
Every quote, post, and endorsement pulled into a single champion bench with sources.
Enroll the advocates already speaking
A program gives willing customers a cadence, a reason, and recognition. Their words, their feeds.
Measure what leadership sees
Reach into the accounts still deciding, tracked per champion and per post, in terms a board trusts.
Claim your full audit
The full audit is not more information. It is the case file for one decision: is this channel worth systematizing at Latent, and what would that take? Leave your name and work email; we verify the request, then send the PDF. Nothing is auto-delivered.
If you do nothing else
Ask the customers already on record to tell their networks why they chose Latent. Their words, their feeds.
It works without us. Kindling exists for what comes after: tracking it, measuring it, and paying advocates fairly at scale.
While the audit is on its way
Sources
- Customer story inventory: latenthealth.com
- Amy Trainor, RN, Chief Information Officer, Ochsner Health: latenthealth.com/case-study/ochsner-case-study-2025
- Harold Scheidel, Specialty Pharmacy Financial Clearance Leader, YNHHS: latenthealth.com/case-study/ynhh-cs-2025-1
- Carla Loessi, Pharmacy Business Director, Medication Access Team, St. Luke's Health System: latenthealth.com/case-study/latent-health-st-lukes-health-system
- Kristi Stice, Director of Ambulatory Pharmacy Services & 340B Compliance, University Health: latenthealth.com/case-study/centralization-playbook
- Janet Perriatt, Pre-Service Authorization Manager, Ochsner Health: latenthealth.com/case-study/ochsner-infusion
- Debbie Simonson, Chief Pharmacy Officer, Ochsner Health: latenthealth.com/case-study/ochsner-latent-appeal
- Ryan Mezinger, Senior Vice President, Chief Pharmacy Officer, MetroHealth: latenthealth.com/case-study/metro-case-study-2025
- Deborah Simonson, VP and Chief Pharmacy Officer, Ochsner Health: latenthealth.com/case-study/cost-center-to-growth-engine
- Dr. Robert Granko, System Vice President, Pharmacy Business Operations, UNC Health: latenthealth.com/case-study/unc-health-medication-access
- investors: Spark Capital, Transformation Capital, General Catalyst, McKesson Ventures: mobihealthnews.com/news/latent-raises-80m-ai-medication-approval-platform
- funding/press article: forbes.com/sites/davidprosser/2025/02/12/how-latent-labs-plans-to-create-medicines-from-scratch-with-ai/